Siemens Healthineers (OTCMKTS:SMMNY) Stock Moved Down to “Strong Sell” by Zacks Research

Zacks Research lowered shares of Siemens Healthineers (OTCMKTS:SMMNY) from a hold rating to a strong sell rating in a research note released on Thursday morning,Zacks reports.

Several other equities analysts have also issued reports on SMMNY. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Siemens Healthineers in a research report on Tuesday, August 18th. Citigroup reissued a “buy” rating on shares of Siemens Healthineers in a research report on Thursday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

Siemens Healthineers Stock Performance

Siemens Healthineers stock opened at $21.29 on Thursday. Siemens Healthineers has a twelve month low of $19.20 and a twelve month high of $28.92. The stock’s 50 day moving average is $22.24 and its 200 day moving average is $21.06.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a Germany-based medical technology company that develops and supplies products, services and digital solutions for healthcare providers. Its portfolio supports medical imaging, laboratory diagnostics, cancer treatment, minimally invasive procedures and related clinical workflows.

The company’s imaging business offers magnetic resonance imaging, computed tomography, molecular imaging, X-ray and ultrasound systems. Its diagnostics activities include laboratory testing, point-of-care testing and diagnostic IT solutions.